WO2001074320A3 - Verwendung von protease-inhibitoren in der kosmetik und pharmazie - Google Patents

Verwendung von protease-inhibitoren in der kosmetik und pharmazie Download PDF

Info

Publication number
WO2001074320A3
WO2001074320A3 PCT/EP2001/003258 EP0103258W WO0174320A3 WO 2001074320 A3 WO2001074320 A3 WO 2001074320A3 EP 0103258 W EP0103258 W EP 0103258W WO 0174320 A3 WO0174320 A3 WO 0174320A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmacy
cosmetics
protease inhibitors
prevention
relates
Prior art date
Application number
PCT/EP2001/003258
Other languages
English (en)
French (fr)
Other versions
WO2001074320A2 (de
Inventor
Dirk Petersohn
Guenter Schmitt
Klaus Rudolf Schroeder
Thomas Foerster
Original Assignee
Henkel Kgaa
Dirk Petersohn
Guenter Schmitt
Klaus Rudolf Schroeder
Thomas Foerster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10020447A external-priority patent/DE10020447A1/de
Application filed by Henkel Kgaa, Dirk Petersohn, Guenter Schmitt, Klaus Rudolf Schroeder, Thomas Foerster filed Critical Henkel Kgaa
Priority to AU2001242502A priority Critical patent/AU2001242502A1/en
Priority to EP01915400A priority patent/EP1267813A2/de
Publication of WO2001074320A2 publication Critical patent/WO2001074320A2/de
Publication of WO2001074320A3 publication Critical patent/WO2001074320A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Die Erfindung betrifft die Verwendung MMP-1-inhibierender Stoffe in kosmetischen Zubereintungen, insbesondere zur Vorbeugung gegen die licht- und wärmeinduzierte Alterung der menschlichen Haut sowie zur Vorbeugung gegen Gingivitis und Parodontitis. Die Erfindung betrifft auch pharmazeutische Zubereitungen mit einem Gehalt an MMP-1-inhibierenden Stoffen.
PCT/EP2001/003258 2000-03-31 2001-03-22 Verwendung von protease-inhibitoren in der kosmetik und pharmazie WO2001074320A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001242502A AU2001242502A1 (en) 2000-03-31 2001-03-22 Use of protease inhibitors in cosmetics and pharmacy
EP01915400A EP1267813A2 (de) 2000-03-31 2001-03-22 Verwendung von protease-inhibitoren in der kosmetik und pharmazie

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10016016.6 2000-03-31
DE10016016 2000-03-31
DE10020447A DE10020447A1 (de) 2000-03-31 2000-04-26 Verwendung von Protease-Inhibitoren in der Kosmetik und Pharmazie
DE10020447.3 2000-04-26

Publications (2)

Publication Number Publication Date
WO2001074320A2 WO2001074320A2 (de) 2001-10-11
WO2001074320A3 true WO2001074320A3 (de) 2002-04-11

Family

ID=26005113

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003258 WO2001074320A2 (de) 2000-03-31 2001-03-22 Verwendung von protease-inhibitoren in der kosmetik und pharmazie

Country Status (3)

Country Link
EP (1) EP1267813A2 (de)
AU (1) AU2001242502A1 (de)
WO (1) WO2001074320A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259014A1 (de) * 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
US7217690B2 (en) 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
SI1591105T1 (sl) 2004-03-17 2020-09-30 Stada Arzneimittel Ag Uporaba antioksidantov za pripravo farmacevtskega ali kozmetičnega sestavka za zaščito kože pred poškodbo z infrardečim sevanjem
ES2310142B1 (es) 2007-06-15 2009-12-04 Lipotec S.A Compuestos reguladores de la pigmentacion.
EP2100594A1 (de) 2008-03-14 2009-09-16 Symrise GmbH & Co. KG Ternäre Mischungen mit Collagensynthese steigernder Wirkung
EP2113242A1 (de) 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidationsmittel für kosmetische, medizinische und pharmazeutische Zubereitungen
CN108299372B (zh) * 2018-04-09 2022-11-04 青岛新虹锐泽机械科技有限公司 一种用于防治牙龈炎的药物及其制备方法

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0514966A2 (de) * 1991-05-17 1992-11-25 Unilever N.V. Zinn-Verbindungen enthaltende Zahnpasten
US5188817A (en) * 1989-03-27 1993-02-23 Julius Ozick Method of treatment for periodontitis
WO1994009756A1 (en) * 1992-11-05 1994-05-11 Unilever Plc Retinol containing cosmetic composition
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
WO1995024921A1 (en) * 1994-03-16 1995-09-21 Institute Of Ophthalmology A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1998036742A1 (en) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
WO1998055075A2 (en) * 1997-06-04 1998-12-10 Regents Of The University Of Michigan Compositions and methods for inhibiting photoaging of skin
FR2772618A1 (fr) * 1997-12-18 1999-06-25 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
DE19834355A1 (de) * 1998-07-30 2000-02-03 Henkel Kgaa Entzündungshemmende Zahnpflegemittel
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
EP1002533A1 (de) * 1998-09-16 2000-05-24 Lipotec, S.A. Verwendung von chromane und/oder chromene Derivate zur Vermeidung von freiesradikal induzierten oxidativen Reaktionen
DE19903716A1 (de) * 1999-01-30 2000-08-03 Henkel Kgaa Antioxidative Hautpflegemittel
JP2000319116A (ja) * 1999-04-30 2000-11-21 Lion Corp 安定化された没食子酸誘導体及びそれを含有する外用剤組成物
JP2001002558A (ja) * 1999-04-19 2001-01-09 Kanebo Ltd 美白化粧料

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808189B1 (fr) * 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188817A (en) * 1989-03-27 1993-02-23 Julius Ozick Method of treatment for periodontitis
EP0514966A2 (de) * 1991-05-17 1992-11-25 Unilever N.V. Zinn-Verbindungen enthaltende Zahnpasten
WO1994009756A1 (en) * 1992-11-05 1994-05-11 Unilever Plc Retinol containing cosmetic composition
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
WO1995024921A1 (en) * 1994-03-16 1995-09-21 Institute Of Ophthalmology A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1998036742A1 (en) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
WO1998055075A2 (en) * 1997-06-04 1998-12-10 Regents Of The University Of Michigan Compositions and methods for inhibiting photoaging of skin
FR2772618A1 (fr) * 1997-12-18 1999-06-25 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
DE19834355A1 (de) * 1998-07-30 2000-02-03 Henkel Kgaa Entzündungshemmende Zahnpflegemittel
EP1002533A1 (de) * 1998-09-16 2000-05-24 Lipotec, S.A. Verwendung von chromane und/oder chromene Derivate zur Vermeidung von freiesradikal induzierten oxidativen Reaktionen
DE19903716A1 (de) * 1999-01-30 2000-08-03 Henkel Kgaa Antioxidative Hautpflegemittel
JP2001002558A (ja) * 1999-04-19 2001-01-09 Kanebo Ltd 美白化粧料
JP2000319116A (ja) * 1999-04-30 2000-11-21 Lion Corp 安定化された没食子酸誘導体及びそれを含有する外用剤組成物

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MIZUSHIMA, NAOKI ET AL: "Stabilized gallic acid derivatives and topical preparations containing them", XP002180404, retrieved from STN Database accession no. 134:9146 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; YOKOTA, TOMOHIRO ET AL: "Cosmetics containing chroman derivatives", XP002180403, retrieved from STN Database accession no. 134:90901 *
KAHN, G. ET AL.: "Ultraviolet light protection by several new compounds", ARCHIVES OF DERMATOLOGY, vol. 109, no. 4, 1974, pages 510 - 517, XP001030767 *
LAW, E. LEWIS, A.J.: "The effect of systemically and topically applied drugs on ultraviolet-induced erythema in the rat", BRITISH JOURNAL OF PHARMACOLOGY, vol. 59, no. 4, 1977, pages 591 - 597, XP001030730 *
LISANTI, V.F., EICHEL, B.: "Antioxidant inhibition of experimentally induced caries in hamsters", JOURNAL OF DENTAL RESEARCH, vol. 42, no. 4, 1963, pages 1030 - 1035, XP001030766 *
See also references of EP1267813A2 *

Also Published As

Publication number Publication date
WO2001074320A2 (de) 2001-10-11
EP1267813A2 (de) 2003-01-02
AU2001242502A1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
WO2002049593A3 (de) Verwendung von dna-reparatur-enzymen als mmp-1-inhibitoren
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
AU2001237433A1 (en) Preparation containing quinoxaline derivatives
EP1250116A4 (de) Pharmazeutische und kosmetische träger oder zusammensetzung zur topischen anwendung
WO2001062223A3 (de) Kosmetische zubereitungen enthaltend pflanzenextrakte
AU2002358653A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
DK1264602T3 (da) Farmaceutiske præparater
HUP0400119A3 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
AU2002361036A1 (en) Cosmetic and/or pharmaceutical emulsions
HUP0304077A3 (en) Pharmaceutical and cosmetic compositions against skin aging
HUP0201821A2 (en) Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
AU2002366451A1 (en) Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
ITMI20020003A0 (it) Contenitore particolaremente studiato per creme cosmetiche e farmaceutiche
WO2001045650A3 (de) Kosmetische verwendung von rückständen aus der weinherstellung
WO2004052353A3 (en) Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
WO2004041173A3 (en) Compositions for darkening the skin and/or hair
FR2730635B1 (fr) Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de bertholletia
WO2003037288A3 (fr) Composition cosmetique mimant le sebum, et utilisations
WO2003011241A8 (de) Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
DE50300126D1 (de) Coffein enthaltende Zusammensetzung als Hauptflegemittel
AU2002224822A1 (en) Cosmetic skin treatment, care or protection composition
WO2002072051A3 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
AU2002367142A1 (en) Ester-containing oils and external preparations for skin and cosmetics containing the oils
WO2002087534A3 (de) Kosmetische oder dermatologische formulierungen mit einem gehalt an sericosid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY BZ CA CN CO CR CU CZ DM DZ EE GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LV MA MD MG MK MN MW MX MZ NO NZ PL RO RU SD SG SI SK SL TJ TM TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY BZ CA CN CO CR CU CZ DM DZ EE GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LV MA MD MG MK MN MW MX MZ NO NZ PL RO RU SD SG SI SK SL TJ TM TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001915400

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001915400

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP